Cost-Effectiveness Analysis of Pirfenidone Versus Nintedanib on The Treatment of Idiopathic Pulmonary Fibrosis
Abstract
Authors
R Ho C Rufino C Lisondo M Alves
R Ho C Rufino C Lisondo M Alves
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now